Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Umbreen Rozell
Assistant Clinical Professor, Medicine - (Clinical Series Track)
Medicine
Overview
Research
More
Collaboration
(14)
Rachna Shroff
Mutual work: 5 Grants﹒5 Proposals
Collaboration Details
Jennifer Segar
Mutual work: 9 Proposals﹒8 Grants
Collaboration Details
Gregory Woodhead
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Hina Arif Tiwari
Mutual work: 4 Grants﹒4 Proposals
Collaboration Details
Brianna Denton
Mutual work: 2 Grants﹒2 Proposals
Collaboration Details
Page 1 of 3
Previous page
Next page
Grants
(13)
EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant Vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for
Active
·
2024
·
$0 / $559.6K
·
External
Co-Investigator (COI)
breast cancer,
adjuvant therapy,
immunotherapy,
clinical trial,
hormone receptor
A Phase 3 Randomized, Open-label Study Of Op-1250 Monotherapy Vs Standard Of Care For The Treatment Of Er+, Her2- Advanced Or Metastatic Breast Cancer Following Endocrine And Cdk 4/6 Inhibitor Therapy
Active
·
2024
·
$0 / $512.6K
·
External
Co-Investigator (COI)
monotherapy,
endocrine therapy,
metastatic breast cancer
A Phase Ib/III, Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Fact
Active
·
2024
·
$2.1M / $352.6K
·
External
Principal Investigator (PI)
cancer treatment,
combination therapy,
clinical trial,
cell signaling
A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer
Active
·
2024
·
$0 / $120.6K
·
External
Co-Investigator (COI)
oncology,
chemotherapy,
hair loss,
clinical trial
MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene Expression Profiles: An Adaptable Registry (FLEX Registry)
Active
·
2024
·
$0 / $39.1K
·
External
Co-Investigator (COI)
gene expression,
clinical data,
registry,
genomic data,
cancer research
Page 1 of 3
Previous page
Next page
Publications
(3)
Recent
Pan tumor outcomes to immune checkpoint inhibitors in patients of Native American origin in the United States: The multicenter POINT-US study.
2023
cancer immunotherapy,
health disparities,
clinical research,
oncology
New Oral Anticoagulants and Their Reversal
2015
anticoagulants,
blood clotting,
pharmacology,
clinical trials
Pervasive and largely lineage-specific adaptive protein evolution in the dosage compensation complex of Drosophila melanogaster
2007
